S
SoftOx Solutions AS
OSE:SOFTX
SoftOx Solutions AS
OSE:SOFTX
Price:
0.1122
NOK
-20.43%
Market Cap:
kr273.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
SoftOx Solutions AS
OSE:SOFTX
|
NO |
|
P
|
Pfizer Inc
SGO:PFE
|
US |
|
Albaraka Turk Katilim Bankasi AS
IST:ALBRK.E
|
TR |
|
EFG Hermes Holdings SAE
LSE:EFGD
|
EG |
|
LookSmart Group Inc
OTC:LKST
|
US |
|
G
|
Great Republic Mining Corp
CNSX:GRM
|
CA |
|
Pan Pacific International Holdings Corp
TSE:7532
|
JP |
Multiples-Based Value
The Multiples-Based Value for SoftOx Solutions AS (SOFTX) under the Base Case is hidden NOK. Compared with the current market price of 0.1122 NOK, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SOFTX Multiples-Based Value
LOCKED
Multiples Across Competitors
SOFTX Competitors Multiples
SoftOx Solutions AS Competitors
SoftOx Solutions AS Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
S
|
SoftOx Solutions AS
OSE:SOFTX
|
315.9m NOK | 23.8 | -16.3 | -16.5 | -13.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD | 13.8 | 43.6 | 29.4 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.4 | 16.8 | 23.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
